Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.10.2023 | Case report

Azithromycin/carbocisteine/cefuroxime

Stevens-Johnson syndrome and intentional drug misuse: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ben Salem C, et al. Carbocisteine-induced Stevens-Johnson syndrome confirmed by inadvertent re-exposure. Journal of the European Academy of Dermatology and Venereology 37: e348-e349, No. 3, 12 Oct 2022. Available from: URL: http://doi.org/10.1111/jdv.18661 Ben Salem C, et al. Carbocisteine-induced Stevens-Johnson syndrome confirmed by inadvertent re-exposure. Journal of the European Academy of Dermatology and Venereology 37: e348-e349, No. 3, 12 Oct 2022. Available from: URL: http://​doi.​org/​10.​1111/​jdv.​18661
Metadaten
Titel
Azithromycin/carbocisteine/cefuroxime
Stevens-Johnson syndrome and intentional drug misuse: case report
Publikationsdatum
01.10.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-47142-8

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Pembrolizumab

Case report

Interferon-beta

Case report

Avelumab